牛牛AI助理已提取核心訊息
Walgreens Boots Alliance, Inc. Director Nancy M. Schlichting is set to sell 15,209 common shares of the company, with an aggregate market value of approximately $349,654, on January 16, 2024. The shares to be sold were acquired through restricted stock awards, with 5,515 shares obtained on November 4, 2022, and 9,694 shares on November 1, 2023, as part of equity compensation from the issuer. There is no recent sale history reported for the past three months.
Walgreens Boots Alliance, Inc. Director Nancy M. Schlichting is set to sell 15,209 common shares of the company, with an aggregate market value of approximately $349,654, on January 16, 2024. The shares to be sold were acquired through restricted stock awards, with 5,515 shares obtained on November 4, 2022, and 9,694 shares on November 1, 2023, as part of equity compensation from the issuer. There is no recent sale history reported for the past three months.
Walgreens Boots Alliance, Inc.董事南希·施利希廷定於2024年1月16日出售該公司的15,209股普通股，總市值約爲349,654美元。待售股票是通過限制性股票獎勵收購的，2022年11月4日獲得5,515股股票，2023年11月1日獲得9,694股，作爲發行人股權補償的一部分。沒有報告過去三個月的近期銷售記錄。
Walgreens Boots Alliance, Inc.董事南希·施利希廷定於2024年1月16日出售該公司的15,209股普通股，總市值約爲349,654美元。待售股票是通過限制性股票獎勵收購的，2022年11月4日獲得5,515股股票，2023年11月1日獲得9,694股，作爲發行人股權補償的一部分。沒有報告過去三個月的近期銷售記錄。
有用
沒用